Hopes raised for next phase of AstraZeneca development in Cambridge after drugmaker commits to £300m spend in UK

By Tom Lowe2026-04-30T06:00:00

Firm reverses decision last year to halt spending because of concerns over drug pricing

Hopes are growing that AstraZeneca will begin procurement on the next phase of its headquarters campus in Cambridge after the drugmaker said it would invest £300m in the UK reversing a previous decision taken last year.

Already registered? Login here

To continue enjoying Building.co.uk, sign up for free guest access

Existing subscriber? LOGIN

Stay at the forefront of thought leadership with news and analysis from award-winning journalists. Enjoy company features, CEO interviews, architectural reviews, technical project know-how and the latest innovations.

Limited access to building.co.uk
Breaking industry news as it happens
Breaking, daily and weekly e-newsletters

Get your free guest access SIGN UP TODAY

Subscribe now for unlimited access

Subscribe to Building today and you will benefit from:

Unlimited access to all stories including expert analysis and comment from industry leaders
Our league tables, cost models and economics data
Our online archive of over 10,000 articles
Building magazine digital editions
Building magazine print editions
Printed/digital supplements

Subscribe now for unlimited access.

View our subscription options and join our community